Commonwealth Fusion Systems (CFS) announced a $1 billion equity funding round on July 30, bringing its total capital raised since 2018 to $4 billion—the single largest fusion-sector raise since CFS's own $1.8 billion Series B in 2021. The round attracted pension funds, sovereign wealth funds, and infrastructure-focused corporate partners, signaling a shift in fusion financing from speculative VC to institutional patient capital.
CFS is now 75–80% complete on SPARC, its demonstration tokamak reactor in Devens, Massachusetts, with first plasma expected late 2026 and net energy gain (Q>1) targeted for 2027. The capital will accelerate SPARC assembly and advance ARC, CFS's commercial-scale grid fusion plant planned for Chesterfield County, Virginia, with a target to deliver power to the grid in the early 2030s.
Major power commitments are secured: Google and Eni signed agreements to purchase more than half of ARC's planned output (Google: 200 MW; Eni: >$1B in electricity purchases). CFS also hired Lorence Kim, former Moderna CFO (2014–2020, through Moderna's 2018 IPO), signaling anticipated capital-raise scale ahead and possible eventual public exit.
For energy-sector investors: CFS now holds ~30% of total fusion-industry capital raised to date. The shift toward institutional LPs and committed offtake agreements (PPAs) reflects real progress in hardware; success at SPARC in 2027 would validate the tokamak path and likely unlock follow-on institutional funding and strategic partnerships for ARC construction.